Swiss perspectives in 10 languages

Scientists develop cancer diagnosis implant

Hand and mole on arm
When too much calcium is detected, the implant triggers the production of melanin, causing a small dark mole to appear (Re-enacted montage: ETH Zurich)

Researchers in Switzerland have developed an implant that can detect common types of cancer in the body and act as an early warning system by causing a small mole to form on skin. 

A team from Zurich’s Federal Institute of Technology (ETHZ)External link have developed a prototype implant which can be inserted under the skin. It contains a network of cells which constantly monitor calcium levels in the body. Cancer can cause calcium levels to rise in the body. The implant detects when a threshold is exceeded and triggers the production of melanin, causing a small dark mole to form. 

+ How Swiss hospitals have joined forces in battle against cancer

The implant can recognise the four most common types of cancer – prostate, lung, colon and breast cancer – at a very early stage. Cancer is the main cause of death alongside cardiovascular disease in industrialised countries. However, many of those affected are only diagnosed after a tumour has developed extensively.

“Early detection increases the chance of survival significantly,” said Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETHZ in Basel. If breast cancer is detected early, for example, the chance of recovery is 98%. However, if the tumour is diagnosed too late, only one in four women has a good chance of recovery.

The implant is intended primarily for self-monitoring, making it very cost effective. However, the service life of such a device is limited, as encapsulated living cells last for about a year. After that, they must be inactivated and replaced.

So far, the prototype early warning device has been tested on mice and on pig skin, where it functioned reliably, the ETHZ wrote. Tests on humans are still years away.

“Continued development and clinical trials in particular are laborious and expensive, which we as a research group cannot afford,” said Fussenegger. He believes it will take another ten years of research and development for a cancer diagnosis implant to be available for sale.

The research was published in Science Translational MedicineExternal link.

Popular Stories

Most Discussed

News

UNRWA provides emergency assistance to just over one million Palestine refugees, or about 75 per cent of all Palestine refugees in Gaza, who lack the financial means to cover their basic food.

More

Lazzarini: no alternative to UNRWA in Gaza

This content was published on The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.

Read more: Lazzarini: no alternative to UNRWA in Gaza
Antibiotic use on the rise again in Switzerland

More

Rise in use of antibiotics in Switzerland

This content was published on The consumption of antibiotics has risen in Switzerland since the Covid-19 pandemic. However, compared to other European countries the Alpine country has one of the lowest levels of antibiotic usage.

Read more: Rise in use of antibiotics in Switzerland

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR